A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy.
Li-Nong JiJinmiao LuLeili GaoXiaoguang YanJifang LiZhifeng ChengLili ZhangJunhang TianPing LiJie BaiDaosheng XieJiahong ZhaoJuping DingQiang YuTong WangPublished in: Diabetes, obesity & metabolism (2023)
The addition of cetagliptin once daily to metformin was more efficacious and well tolerated than metformin monotherapy in Chinese patients with type 2 diabetes who had inadequate glycaemic control with metformin monotherapy.